Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Accelr8 Technology Corp.
Accelr8 Announces Publication of New Study on its OptiChem High-Performance Bio-Coatings
September 26th, 2008
Accelr8 Technology Corporation (Amex: AXK) announced that two teams of university research collaborators report new methods for scalable production with the company's patented OptiChem(R) bio-coatings. Led by Dr. David Grainger at the University of Utah, researchers from the University of Utah, the University of Washington, and Accelr8 developed production-scalable methods to make OptiChem surface micro-patterns for live-cell and biomolecular attachment. The new study overcame the technical obstacles that have limited previous high-performance, patterned bio-coatings to laboratory-scale fabrication. Examples of potential applications include cell patterning for...
Source: Health Business Week (2008-09-26)
|
